LumiThera

CompanyUnited States

LumiThera develops one asset, in human trials (Valeda Light Delivery System in dry age-related macular degeneration). Mostly device; based in the United States.

1
Asset
Furthest: Human trials; 1
Trial: 2
Signals

Pipeline

1

Valeda Light Delivery System
Delivers photobiomodulation light to support mitochondrial function in retinal cells.
Human trials, Device, dry age-related macular degeneration

Full company profiles: pipeline, trials, funding and people.

In the full profile

Trials1
Signals2
Similar companies6

Updated 10 Oct 2026 · 2 sources